134 related articles for article (PubMed ID: 17309571)
21. Saving Medicare. What can we do?
Gibson G
Can Fam Physician; 1993 Aug; 39():1704-8. PubMed ID: 8374352
[No Abstract] [Full Text] [Related]
22. Continuous infusion of calcium gluconate in 5% albumin is safe and prevents most hypocalcemic reactions during therapeutic plasma exchange.
Kankirawatana S; Huang ST; Marques MB
J Clin Apher; 2007; 22(5):265-9. PubMed ID: 17722047
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of pediatric plasma apheresis in intensive care settings.
Haque A; Sher G; Hoda M; Moiz B
Ther Apher Dial; 2014 Oct; 18(5):497-501. PubMed ID: 24674133
[TBL] [Abstract][Full Text] [Related]
24. Periodic therapeutic plasma exchange in patients with moderate to severe chronic myasthenia gravis non-responsive to immunosuppressive agents: an eight year follow-up.
Triantafyllou NI; Grapsa EI; Kararizou E; Psimenou E; Lagguranis A; Dimopoulos A
Ther Apher Dial; 2009 Jun; 13(3):174-8. PubMed ID: 19527462
[TBL] [Abstract][Full Text] [Related]
25. Trends in clinical hemapheresis 1986. Progress report on the 4th annual meeting of the European Society for Hemapheresis.
Nydegger UE; Vaudaux P; Castelli D
Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():4-6. PubMed ID: 3119490
[TBL] [Abstract][Full Text] [Related]
26. Recognition of intercenter differences may help develop best practice.
Norda R; Axelsson CG; Axdorph U; Berlin G; Wikström B; Stegmayr B;
Ther Apher Dial; 2008 Oct; 12(5):347-54. PubMed ID: 18937716
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic hemapheresis].
Taraldsrud E; Aandahl GS; Stavem K; Kvalheim G; Jørstad S
Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2439-42. PubMed ID: 14594145
[TBL] [Abstract][Full Text] [Related]
28. Pediatric therapeutic plasma exchange indications and patterns of use in US children's hospitals.
Weiss PF; Klink AJ; Friedman DF; Feudtner C
J Clin Apher; 2012; 27(6):287-94. PubMed ID: 22811262
[TBL] [Abstract][Full Text] [Related]
29. Clinical applications of therapeutic apheresis.
Balogun RA; Kaplan A; Ward DM; Okafor C; Burns TM; Torloni AS; Macik BG; Abdel-Rahman EM
J Clin Apher; 2010; 25(5):250-64. PubMed ID: 20806279
[No Abstract] [Full Text] [Related]
30. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service.
Johnson KK; Duvall D; Gilcher RO; Smith JW; Forsberg JE; Terrell DR; Vesely SK; George JN
J Okla State Med Assoc; 2007 Jul; 100(7):273-8. PubMed ID: 17896615
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases.
Yücesan C; Arslan O; Arat M; Yücemen N; Ayyildiz E; Ilhan O; Mutluer N
Transfus Apher Sci; 2007 Feb; 36(1):103-7. PubMed ID: 17224307
[TBL] [Abstract][Full Text] [Related]
32. [Family physician EMB. Insurance case reimbursement advantageous for large practices].
Zimmermann GW
MMW Fortschr Med; 2007 Nov; 149(47):9-10. PubMed ID: 18064810
[No Abstract] [Full Text] [Related]
33. Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures.
Kiprov DD; Golden P; Rohe R; Smith S; Hofmann J; Hunnicutt J
J Clin Apher; 2001; 16(3):130-3. PubMed ID: 11746539
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic plasma exchange in Mexico: experience from a single institution.
Lazo-Langner A; Espinosa-Poblano I; Tirado-Cárdenas N; Ramírez-Arvizu P; López-Salmorán J; Peñaloza-Ramírez P; Sánchez-Guerrero SA
Am J Hematol; 2002 May; 70(1):16-21. PubMed ID: 11994977
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic applications of hemapheresis].
Huestis DW; Pineda AA
Sangre (Barc); 1982; 27(6):1059-72. PubMed ID: 6764036
[No Abstract] [Full Text] [Related]
36. Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy.
Kasper S; Neurath MF; Huber C; Theobald M; Scharrer I
Transfusion; 2007 Jul; 47(7):1263-7. PubMed ID: 17581162
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic plasma exchange: a paired comparison of Fresenius AS104 vs. COBE Spectra.
Burgstaler EA; Pineda AA
J Clin Apher; 2001; 16(2):61-6. PubMed ID: 11746530
[TBL] [Abstract][Full Text] [Related]
38. [Regress prevention. Attention, trap in consultation need].
MMW Fortschr Med; 2005 Oct; 147(40):49. PubMed ID: 16255518
[No Abstract] [Full Text] [Related]
39. [Public insurance, health premium, business tax for physicians... much remains obscured].
MMW Fortschr Med; 2005 Sep; 147(37):56-7. PubMed ID: 16193880
[No Abstract] [Full Text] [Related]
40. [National survey of the therapeutic apheresis in Hungary, 2013-2017].
Soltész P
Orv Hetil; 2019 May; 160(19):727-738. PubMed ID: 31055962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
